| 1 |
In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam |
|
| | Wantin Sribenjalux, Lumyai Wonglakorn, Atibordee Meesing | | | Journal of Global Antimicrobial Resistance. 2022; 28: 8 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Case of melioidosis misdiagnosed as pulmonary tuberculosis |
|
| | Chitra Veluthat, Kavitha Venkatnarayan, Priyadarshini Padaki, Uma Maheswari Krishnaswamy | | | BMJ Case Reports. 2021; 14(5): e242499 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Melioidosis in aspects of epidemiology, clinic, and laboratory diagnostics |
|
| | I. B. Zakharova, A. V. Toporkov, D. V. Viktorov | | | Russian Journal of Infection and Immunity. 2021; 11(3): 409 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Misidentification of Burkholderia pseudomallei, China |
|
| | Bin Wu, Xinxin Tong, Haoyan He, Yinmei Yang, Huling Chen, Xiao Yang, Banglao Xu | | | Emerging Infectious Diseases. 2021; 27(3): 964 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Human Melioidosis |
|
| | I. Gassiep, M. Armstrong, R. Norton | | | Clinical Microbiology Reviews. 2020; 33(2) | | | [Pubmed] [Google Scholar] [DOI] | |
|
